268 related articles for article (PubMed ID: 33828530)
21. Targeting mTOR and Metabolism in Cancer: Lessons and Innovations.
Magaway C; Kim E; Jacinto E
Cells; 2019 Dec; 8(12):. PubMed ID: 31817676
[TBL] [Abstract][Full Text] [Related]
22. AMPK activation protects astrocytes from hypoxia‑induced cell death.
Barialai L; Strecker MI; Luger AL; Jäger M; Bruns I; Sittig ACM; Mildenberger IC; Heller SM; Delaidelli A; Lorenz NI; Voss M; Ronellenfitsch MW; Steinbach JP; Burger MC
Int J Mol Med; 2020 May; 45(5):1385-1396. PubMed ID: 32323755
[TBL] [Abstract][Full Text] [Related]
23. Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart.
Sharma S; Guthrie PH; Chan SS; Haq S; Taegtmeyer H
Cardiovasc Res; 2007 Oct; 76(1):71-80. PubMed ID: 17553476
[TBL] [Abstract][Full Text] [Related]
24. Effects of AMP-activated protein kinase (AMPK) signaling and essential amino acids on mammalian target of rapamycin (mTOR) signaling and protein synthesis rates in mammary cells.
Appuhamy JA; Nayananjalie WA; England EM; Gerrard DE; Akers RM; Hanigan MD
J Dairy Sci; 2014; 97(1):419-29. PubMed ID: 24183687
[TBL] [Abstract][Full Text] [Related]
25. Human Protein Kinases and Obesity.
Engin A
Adv Exp Med Biol; 2017; 960():111-134. PubMed ID: 28585197
[TBL] [Abstract][Full Text] [Related]
26. An emerging role for TOR signaling in mammalian tissue and stem cell physiology.
Russell RC; Fang C; Guan KL
Development; 2011 Aug; 138(16):3343-56. PubMed ID: 21791526
[TBL] [Abstract][Full Text] [Related]
27. The AMP-activated protein kinase (AMPK) and cancer: many faces of a metabolic regulator.
Faubert B; Vincent EE; Poffenberger MC; Jones RG
Cancer Lett; 2015 Jan; 356(2 Pt A):165-70. PubMed ID: 24486219
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia.
Tabe Y; Tafuri A; Sekihara K; Yang H; Konopleva M
Expert Opin Ther Targets; 2017 Jul; 21(7):705-714. PubMed ID: 28537457
[TBL] [Abstract][Full Text] [Related]
29. Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells.
Martelli AM; Evangelisti C; Follo MY; Ramazzotti G; Fini M; Giardino R; Manzoli L; McCubrey JA; Cocco L
Curr Med Chem; 2011; 18(18):2715-26. PubMed ID: 21649579
[TBL] [Abstract][Full Text] [Related]
30. Autoregulation of the mechanistic target of rapamycin (mTOR) complex 2 integrity is controlled by an ATP-dependent mechanism.
Chen CH; Kiyan V; Zhylkibayev AA; Kazyken D; Bulgakova O; Page KE; Bersimbaev RI; Spooner E; Sarbassov DD
J Biol Chem; 2013 Sep; 288(38):27019-27030. PubMed ID: 23928304
[TBL] [Abstract][Full Text] [Related]
31. Discordant signaling and autophagy response to fasting in hearts of obese mice: Implications for ischemia tolerance.
Andres AM; Kooren JA; Parker SJ; Tucker KC; Ravindran N; Ito BR; Huang C; Venkatraman V; Van Eyk JE; Gottlieb RA; Mentzer RM
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H219-28. PubMed ID: 27199111
[TBL] [Abstract][Full Text] [Related]
32. Oxidative Stress and Decreased Mitochondrial Superoxide Dismutase 2 and Peroxiredoxins 1 and 4 Based Mechanism of Concurrent Activation of AMPK and mTOR in Alzheimer's Disease.
Majd S; Power JHT
Curr Alzheimer Res; 2018; 15(8):764-776. PubMed ID: 29473507
[TBL] [Abstract][Full Text] [Related]
33. Impaired Cellular Energy Metabolism Contributes to Duck-Enteritis-Virus-Induced Autophagy via the AMPK-TSC2-MTOR Signaling Pathway.
Yin H; Zhao L; Li S; Xu L; Wang Y; Chen H
Front Cell Infect Microbiol; 2017; 7():423. PubMed ID: 29018776
[TBL] [Abstract][Full Text] [Related]
34. Oncogenes strike a balance between cellular growth and homeostasis.
Qiu B; Simon MC
Semin Cell Dev Biol; 2015 Jul; 43():3-10. PubMed ID: 26277544
[TBL] [Abstract][Full Text] [Related]
35. TOR Signaling and Nutrient Sensing.
Dobrenel T; Caldana C; Hanson J; Robaglia C; Vincentz M; Veit B; Meyer C
Annu Rev Plant Biol; 2016 Apr; 67():261-85. PubMed ID: 26905651
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of cardiomyogenesis of embryonic stem cells by nitric oxide downstream of AMP-activated protein kinase and mTOR signaling pathways.
Padmasekar M; Sharifpanah F; Finkensieper A; Wartenberg M; Sauer H
Stem Cells Dev; 2011 Dec; 20(12):2163-75. PubMed ID: 21470048
[TBL] [Abstract][Full Text] [Related]
37. Autophagy regulation by nutrient signaling.
Russell RC; Yuan HX; Guan KL
Cell Res; 2014 Jan; 24(1):42-57. PubMed ID: 24343578
[TBL] [Abstract][Full Text] [Related]
38. mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvation.
Moloughney JG; Vega-Cotto NM; Liu S; Patel C; Kim PK; Wu CC; Albaciete D; Magaway C; Chang A; Rajput S; Su X; Werlen G; Jacinto E
J Biol Chem; 2018 Oct; 293(42):16464-16478. PubMed ID: 30201609
[TBL] [Abstract][Full Text] [Related]
39. Nutrient withdrawal rescues growth factor-deprived cells from mTOR-dependent damage.
Panieri E; Toietta G; Mele M; Labate V; Ranieri SC; Fusco S; Tesori V; Antonini A; Maulucci G; De Spirito M; Galeotti T; Pani G
Aging (Albany NY); 2010 Aug; 2(8):487-503. PubMed ID: 20739737
[TBL] [Abstract][Full Text] [Related]
40. Regulatory role of hexosamine biosynthetic pathway on hepatic cancer stem cell marker CD133 under low glucose conditions.
Lin SH; Liu T; Ming X; Tang Z; Fu L; Schmitt-Kopplin P; Kanawati B; Guan XY; Cai Z
Sci Rep; 2016 Feb; 6():21184. PubMed ID: 26878908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
